Faith Group

The Blood Grouping Reagents Market is experiencing rapid growth due to increasing demand for safe blood transfusions and advancements in blood typing technologies. Hospitals, blood banks, and diagnostic laboratories are expanding their use of reagents to ensure accurate blood group identification, reducing the risk of transfusion errors.

Technological innovations, including automation and AI-assisted blood typing systems, are improving efficiency and reducing manual errors. Research initiatives and growing awareness of blood safety practices also contribute to market expansion.

Market Outlook: The global market was valued at USD 1.2 billion in 2024 and is expected to reach USD 2.5 billion by 2034, growing at a CAGR of 7.1%.